Krane Funds Advisors LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.

Quarter-by-quarter ownership
Krane Funds Advisors LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$14,0000.0%1210.0%0.00%0.0%
Q4 2020$14,000
+40.0%
121
+40.7%
0.00%
Q3 2020$10,000
+150.0%
86
+100.0%
0.00%
Q2 2020$4,000
-42.9%
43
-30.6%
0.00%
Q1 2020$7,0000.0%620.0%0.00%
Q4 2019$7,000
-36.4%
62
-34.0%
0.00%
-100.0%
Q3 2019$11,000
+22.2%
940.0%0.00%0.0%
Q2 2019$9,000
-100.0%
94
-81.4%
0.00%
-66.7%
Q1 2019$46,173,000
+128158.3%
506
+7.0%
0.00%
+50.0%
Q4 2018$36,000
+176.9%
473
+228.5%
0.00%
+100.0%
Q3 2018$13,0001440.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders